Dr. Alice Chen, DO

Dr. Chen practices at Plano Family Medicine in Plano, Texas.

Dr. Chen's NPI, 1841491685, was assigned on May 30, 2007. Dr. Chen graduated from Kirksville College of Osteopathic Medicine in 2006. Dr. Chen holds Texas license M8593.

Dr. Chen's primary practice is Plano Family Medicine, at 1220 Coit Rd Ste 105, Plano, TX 75075-7757. The practice phone is (972) 889-8888.

Dr. Chen's primary practice is Plano Family Medicine in Plano, Texas. Dr. Chen is also affiliated with Medical City Plano Hospital. The medical group on file is Green Oaks Physical Therapy. Dmand AI also links Dr. Chen to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chen is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chen is licensed in Texas.

Dmand AI lists acid reflux, acute skin infection, alzheimer's disease, aneurysm, anxiety, arthritis, asthma and atrial fibrillation and flutter among the conditions Dr. Chen treats.

CMS data shows 3,473 Medicare services from Dr. Chen across 20 procedure codes in 2024, for 232 Medicare patients. Medicare paid $139,137 for them. Every service was in an office.

CMS counts 232 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 13% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 64, with 60% women.

In 2024, Dr. Chen wrote 6,508 Medicare Part D claims for 571 patients. 88% of them were for generic drugs. CMS names the drug for 5,989 of them, across 95 drugs with 11 or more claims each, at $478,972 in total drug cost. In 2023, CMS named 5,318 claims across 87 drugs.

Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 184 papers to Dr. Chen, published from 2010 to 2025. 2019 was the busiest year, with 18. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Benzimidazoles. Dr. Chen has published most often in Clin Cancer Res. Dr. Chen's most frequent co-authors are Robert Gray, MD, Geraldine H. O'Sullivan Coyne, MD, PhD and Naoko Takebe, MD, PhD.

Dmand AI links Dr. Chen to 4 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Desmoid Tumors, Sarcoma, Alveolar Soft Part and Fibroma. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 254 general payments to Dr. Chen from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Gilead Sciences, Inc. paid the most, $9,603.

Dr. Chen graduated from Kirksville College of Osteopathic Medicine in 2006.

Dr. Chen is in network with 20 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.